Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men i...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2007
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
id |
oai:doaj.org-article:b45567b05e58473f8e6434d1cd6ff6ca |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b45567b05e58473f8e6434d1cd6ff6ca2021-12-02T06:16:46ZReview of the safety and efficacy of risedronate for the treatment of male osteoporosis1178-1998https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca2007-10-01T00:00:00Zhttps://www.dovepress.com/review-of-the-safety-and-efficacy-of-risedronate-for-the-treatment-of--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men is an increasingly recognized problem with associated fracture morbidity and mortality. Treatment is limited, with the bisphosphonates being the mainstay of therapy. Risedronate has demonstrated fracture efficacy in women and efficacy has been recently been investigated in men. In men, risedronate either maintains or increases bone mineral density. In placebo controlled trials it has been shown to be safe and effective in preventing fractures.Keywords: male osteoporosis, risedronate, bone mineral density, fracturesRaja BobbaJonathan D AdachiDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 2, Pp 275-282 (2007) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Geriatrics RC952-954.6 |
spellingShingle |
Geriatrics RC952-954.6 Raja Bobba Jonathan D Adachi Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
description |
Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men is an increasingly recognized problem with associated fracture morbidity and mortality. Treatment is limited, with the bisphosphonates being the mainstay of therapy. Risedronate has demonstrated fracture efficacy in women and efficacy has been recently been investigated in men. In men, risedronate either maintains or increases bone mineral density. In placebo controlled trials it has been shown to be safe and effective in preventing fractures.Keywords: male osteoporosis, risedronate, bone mineral density, fractures |
format |
article |
author |
Raja Bobba Jonathan D Adachi |
author_facet |
Raja Bobba Jonathan D Adachi |
author_sort |
Raja Bobba |
title |
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
title_short |
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
title_full |
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
title_fullStr |
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
title_full_unstemmed |
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
title_sort |
review of the safety and efficacy of risedronate for the treatment of male osteoporosis |
publisher |
Dove Medical Press |
publishDate |
2007 |
url |
https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca |
work_keys_str_mv |
AT rajabobba reviewofthesafetyandefficacyofrisedronateforthetreatmentofmaleosteoporosis AT jonathandadachi reviewofthesafetyandefficacyofrisedronateforthetreatmentofmaleosteoporosis |
_version_ |
1718400011275862016 |